address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,forwardPE,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,cryptoTradeable,shortName,longName,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChangePercent,regularMarketPrice,marketState,trailingPegRatio
Virdings AllE 2,Uppsala,754 50,Sweden,46 84 46 42 99,https://www.klaria.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, as well as opioid overdose and anaphylactic shock. Its product pipeline includes Sumatriptan, a novel the treatment of migraine which is in final stage of approval; Epinephrine/Adrenaline which is in Phase I clinical trial for the treatment of acute allergic reaction; and Sirolimus which is in pre-clinical stage for prevention of organ transplant rejection. Further, the company engages in the commercialization of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquartered in Uppsala, Sweden.",4,"[{'maxAge': 1, 'name': 'Mr. Scott  Boyer', 'age': 62, 'title': 'CEO & Director', 'yearBorn': 1962, 'fiscalYear': 2024, 'totalPay': 1914000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Hans  Richter', 'age': 75, 'title': 'Chief Financial Officer', 'yearBorn': 1949, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Marc  Willuhn Ph.D.', 'age': 55, 'title': 'Head of Chemistry, Manufacturing & Control', 'yearBorn': 1969, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Hans  Olivecrona M.D., Ph.D.', 'age': 66, 'title': 'Chief Medical Officer', 'yearBorn': 1958, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,4,0.43,0.429,0.42,0.49,0.43,0.429,0.42,0.49,0.0,1.172,1094242,1094242,619629,1059438,1059438,0.45,0.475,0,0,72766472,0.25,1.81,6.5496373,0.5830241,0.785781,0.0,0.0,SEK,False,58412132,Infinity,0.0,102780175,148503008,0.09020001,0.03833,149972992,0.012,40.833332,1735603200,1767139200,1743379200,-37456000,-0.27,0.0,5.258,-6.157,0.6333333,0.1116153,EQUITY,0.49,1.0,1.0,1.0,1.0,none,1,1520000,0.011,-9487000,0,0.059,0.059,11110000,0.083,-0.20887,-2.42347,11110000,67081500,-3155000,72.049,1.0,-0.85392,0.33244,SEK,KLAR.ST,en-US,US,Equity,Delayed Quote,True,HIGH,False,1445410800000,0.060000002,0.42 - 0.49,Stockholm,619629,0.24000001,0.96000004,0.25 - 1.81,-1.3199999,-0.7292818,63.333332,1621594740,1621594740,-0.27,0.0,0.1,4.9,-0.093024075,-0.15955442,-0.29578102,-0.3764166,15,0,False,Klaria Pharma Holding AB,Klaria Pharma Holding AB (publ.),[],1752247782,STO,finmb_290845813,Europe/Stockholm,CEST,7200000,se_market,False,13.953489,0.49,CLOSED,
